|
Real-time Estimate
Cboe BZX
20:00:00 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 137.66 USD | -3.47% |
|
+10.76% | +357.49% |
| 08-28 | BioNTech Terminates Phase 2 Colorectal Cancer Clinical Trial; Shares Fall | MT |
| 08-28 | FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech, Novavax -- Update | DJ |
Chart: Technical Analysis
Stock exchange
Kazakhstan S.E.
MRNA_KZ 142.60 $
+125.35%
155K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| MRNA | 137.99USD | -3.35% | 3.56B $ | |
CBOE
| MRNA | 137.93USD | -3.38% | 105M $ | |
|
Xetra
| 0QF | 117.46EUR | -1.64% | 6.7M € | |
|
Tradegate
| 0QF | 119.10EUR | -2.81% | 6.26M € | |
|
Borsa Italiana
| 1MRNA | 127.06EUR | -6.53% | 4.83M € | |
|
Boerse Muenchen
| 0QF | 118.30EUR | -3.33% | 3.09M € | |
|
CBOE
| 117.46EUR | -1.87% | 1.44M € | ||
|
CBOE
| 0A45 | 117.62EUR | -1.95% | 737K € | |
|
Börse Stuttgart
| 0QF | 118.76EUR | -3.65% | 379K € | |
|
Wiener Boerse
| MRNA | 118.04EUR | -1.27% | 200K € | |
|
Mexican S.E.
| MRNA * | 2,341.00MXN | -2.57% | 3.44M $ | |
|
Kazakhstan S.E.
| MRNA_KZ | 142.60USD | +125.35% | 155K $ | |
|
Deutsche Boerse AG
| 0QF | 118.60EUR | -3.01% | 122K € | |
|
London S.E.
| 0A45 | 137.60USD | -4.84% | 137K $ | |
|
Swiss Exchange
| MRNA | 138.80USD | -0.81% | 26.51K $ | |
|
Swiss Exchange
| MRNA | 118.18CHF | +5.09% | 1.77K CHF | |
|
Lima
| MRNAUS | 128.96USD | 0.00% | 0 $ | |
Sao Paulo
| M1RN34 | 36.24BRL | -0.71% | 6.18M R$ | |
Buenos Aires S.E.
| MRNA | 11,620.00ARS | -3.81% | 1.78B $ |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- MRNA Stock
- MRNA_KZ Stock
- Charts Moderna, Inc.
Select your edition
All financial news and data tailored to specific country editions
